Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$4.18B |
| 2 |
Tesla
TSLA
|
+$4.01B |
| 3 |
Fidelity Investment Grade Securitized ETF
FSEC
|
+$1.97B |
| 4 |
Applovin
APP
|
+$1.93B |
| 5 |
Boeing
BA
|
+$1.5B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
Apple
AAPL
|
+$5.56B |
| 3 |
Uber
UBER
|
+$3.37B |
| 4 |
Eli Lilly
LLY
|
+$1.93B |
| 5 |
Advanced Micro Devices
AMD
|
+$1.6B |
Sector Composition
| 1 | Technology | 31.31% |
| 2 | Financials | 12.11% |
| 3 | Communication Services | 12% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Healthcare | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Exelixis
EXEL
$10.5B
| $98.2M | 0.01% |
2,947,599
+485,527
| +20% | +$16.2M |
|
1127
California Resources
CRC
$4.41B
| $98M | 0.01% |
1,888,442
-400,660
| -18% | -$20.8M |
|
1128
Planet Fitness
PLNT
$8.61B
| $97.8M | 0.01% |
989,642
+194,157
| +24% | +$19.2M |
|
1129
Schwab International Equity ETF
SCHF
$51.2B
| $97.8M | 0.01% |
5,284,455
+122,431
| +2% | +$2.26M |
|
1130
Varonis Systems
VRNS
$6.4B
| $97.4M | 0.01% |
2,192,098
+256,303
| +13% | +$11.4M |
|
|
RAPP
1131
Rapport Therapeutics
RAPP
$912M
| $97.3M | 0.01% |
5,486,468
| – | – |
|
1132
Dianthus Therapeutics
DNTH
$1.17B
| $96.8M | 0.01% |
4,439,281
+36,133
| +0.8% | +$788K |
|
1133
QCR Holdings
QCRH
$1.31B
| $96.4M | 0.01% |
1,195,735
-259,778
| -18% | -$20.9M |
|
1134
NCR Voyix
VYX
$1.77B
| $96.3M | 0.01% |
6,958,306
-198,925
| -3% | -$2.75M |
|
|
PSTX
1135
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $96.1M | 0.01% |
10,011,617
-4,558,461
| -31% | -$43.8M |
|
1136
COPT Defense Properties
CDP
$3.44B
| $95.9M | 0.01% |
3,099,052
+335,775
| +12% | +$10.4M |
|
1137
Arrowhead Research
ARWR
$4.19B
| $95.9M | 0.01% |
5,101,083
-966,486
| -16% | -$18.2M |
|
1138
XP
XP
$9.98B
| $95.2M | 0.01% |
8,033,223
-2,557,458
| -24% | -$30.3M |
|
1139
MPLX
MPLX
$51.8B
| $95M | 0.01% |
1,985,181
+1,161,714
| +141% | +$55.6M |
|
1140
Rocket Lab Corporation Common Stock
RKLB
$24.4B
| $94.1M | 0.01% |
3,696,136
+3,684,195
| +30,853% | +$93.8M |
|
|
BCPC
1141
Balchem Corporation
BCPC
$5.09B
| $94M | 0.01% |
576,994
+79,499
| +16% | +$13M |
|
1142
Peloton Interactive
PTON
$3.07B
| $93.6M | 0.01% |
10,757,281
+10,696,528
| +17,607% | +$93.1M |
|
1143
JPMorgan Ultra-Short Municipal Income ETF
JMST
$4.4B
| $93.2M | 0.01% |
1,837,552
+41,774
| +2% | +$2.12M |
|
1144
Vanguard Mid-Cap ETF
VO
$88.2B
| $92.8M | 0.01% |
351,475
+10,552
| +3% | +$2.79M |
|
1145
Cushman & Wakefield
CWK
$3.83B
| $92.8M | 0.01% |
7,095,080
-275,378
| -4% | -$3.6M |
|
1146
VanEck High Yield Muni ETF
HYD
$3.37B
| $92.5M | 0.01% |
1,782,883
+1,014,701
| +132% | +$52.7M |
|
1147
Church & Dwight Co
CHD
$22.8B
| $92.5M | 0.01% |
883,340
+43,378
| +5% | +$4.54M |
|
1148
Concentrix
CNXC
$3.35B
| $92.2M | 0.01% |
2,130,949
-3,467,909
| -62% | -$150M |
|
1149
Fox Class A
FOXA
$28.8B
| $91.6M | 0.01% |
1,884,927
+1,330,908
| +240% | +$64.7M |
|
1150
BGC Group
BGC
$4.83B
| $91.6M | 0.01% |
10,105,017
-310,964
| -3% | -$2.82M |
|